Jakob Passweg

Research interests

Publications

• Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

  The Lancet Haematology · 2024 · https://doi.org/10.1016/s2352-3026(23)00342-3

• Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2109965

• Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

  Bone Marrow Transplantation · 2021 · https://doi.org/10.1038/s41409-021-01227-8

• Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

  The Lancet Haematology · 2020 · https://doi.org/10.1016/s2352-3026(19)30256-x

• Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion

  Nature · 2019 · 10.1038/s41586-019-1410-1

• Molecular Minimal Residual Disease in Acute Myeloid Leukemia

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1716863

• Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

  Blood · 2017 · https://doi.org/10.1182/blood-2016-06-724500

• Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

  Bone Marrow Transplantation · 2017 · https://doi.org/10.1038/bmt.2017.34

• Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

  Bone Marrow Transplantation · 2016 · 10.1038/bmt.2016.18

• Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

  Bone Marrow Transplantation · 2016 · https://doi.org/10.1038/bmt.2016.20

• Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

  Leukemia · 2015 · https://doi.org/10.1038/leu.2015.212

• One million haemopoietic stem-cell transplants: a retrospective observational study

  The Lancet Haematology · 2015 · https://doi.org/10.1016/s2352-3026(15)00028-9

• Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

  Blood · 2014 · 10.1182/blood-2013-11-537167

• High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

  Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.45.9628

• Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

  Bone Marrow Transplantation · 2013 · https://doi.org/10.1038/bmt.2013.107

• Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

  Bone Marrow Transplantation · 2011 · 10.1038/bmt.2011.185

• Risk score for outcome after allogeneic hematopoietic stem cell transplantation

  Cancer · 2009 · https://doi.org/10.1002/cncr.24531

• Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

  Bone Marrow Transplantation · 2009 · https://doi.org/10.1038/bmt.2009.141

• Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

  Blood · 2007 · 10.1182/blood-2007-03-081596

• Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation

  Haematologica · 2007 · 10.3324/haematol.10075

• Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

  Bone Marrow Transplantation · 2006 · https://doi.org/10.1038/sj.bmt.1705265

• A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa051113

• Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant Recipients

  New England Journal of Medicine · 2002 · https://doi.org/10.1056/nejmoa020439

• Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

  Annals of the Rheumatic Diseases · 2001 · 10.1136/ard.60.6.577

• Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

  New England Journal of Medicine · 1999 · https://doi.org/10.1056/nejm199907013410103

• Solid Cancers after Bone Marrow Transplantation

  New England Journal of Medicine · 1997 · https://doi.org/10.1056/nejm199703273361301

• IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE

  British Journal of Haematology · 1997 · 10.1046/j.1365-2141.1997.1112925.x

Current projects

No projects listed.